Loading stock data…
Alphatec Holdings, Inc. (ATEC)
$9.19-0.26 (-2.75%)
After Hours$9.19+0.00 (+0.00%)· Last close Sep 8
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alphatec Holdings, Inc. in the Healthcare sector is trading at $9.19 with a market capitalization of $1.5B. Wall Street consensus targets $15.79 (14 analysts), implying a +71.8% move over the next 12 months. The stock is currently near its 52-week low of $6.82, remaining 26.5% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +71.8% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $213.51M↑ | $192.11M↓ | $212.93M↑ | $196.50M↑ | $185.54M |
| Gross Profit | $154.10M↑ | $136.48M↓ | $149.49M↑ | $137.30M↑ | $129.10M |
| Operating Income | -$1.99M↑ | -$22.06M↓ | -$5.36M↑ | -$9.41M↑ | -$11.48M |
| Net Income | -$25.78M↑ | -$33.91M↓ | -$21.73M↑ | -$28.58M↑ | -$41.14M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, ima...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.46B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.85
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
911.38%
Volume
Today's trading volume
1.76M
Recent News
Alphatec (ATEC) Q2 2026 Earnings Call Transcript
Surgical case volume surged 20% as EOS Insight adoption accelerated.
Narrower Losses And Reaffirmed 2026 Revenue Guidance Might Change The Case For Investing In Alphatec Holdings (ATEC)
Alphatec Holdings, Inc. recently reported past second-quarter 2026 results showing its net loss narrowed to US$25.78 million, or US$0.16 per share, and reaffirmed full-year 2026 revenue guidance of about US$882 million, including US$805 million of surgical revenue and US$77 million of EOS revenue. Alongside filing an US$8.12 million employee stock ownership plan shelf registration, the company’s reduced losses and maintained outlook highlight management’s confidence in its current growth and...
Alphatec Holdings, Inc. Q2 2026 Earnings Call Summary
Moby summary of Alphatec Holdings, Inc.'s Q2 2026 earnings call
Alphatec Holdings Inc (ATEC) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
Alphatec Holdings Inc (ATEC) delivered 15% revenue growth and raised its full-year adjusted EBITDA outlook, while navigating a slower-than-expected biologics attachment recovery.
Alphatec (ATEC) Q2 Earnings Lag Estimates
Alphatec (ATEC) delivered earnings and revenue surprises of -22.22% and +1.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?